CSL and Arcturus Therapeutics have announced that Japan’s Ministry of Health, Labor and Welfare has granted approval for ...

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

COVID-19 vaccine developed by Australian biotechnology company CSL and sa-mRNA pioneer Arcturus Therapeutics has been granted ...

Australian biotechnology company CSL Ltd. (CSL.AX, CSLLY.PK) and sa-mRNA pioneer Arcturus Therapeutics (ARCT), announced Friday that ...

Researchers studied more than 1,000 people living with this syndrome to find out this top long COVID symptom. They found that ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

King of Prussia, Pennsylvania Monday, September 16, 2024, 17:00 Hrs [IST] ...

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...